Carlos Cuesta‐Mateos

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

Emma Andersson, S. Pützer, Bhagwan Yadav et al. · Leukemia · 2017 · 95 citations

Novel Drug Sensitivities, Pharmaceutical Research, Drug Target +12

The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model

Marina García-Peydró, Patricia Fuentes, Marta Mosquera et al. · Journal of Clinical Investigation · 2018 · 61 citations · Full text

Active Notch1, Lymphocyte Development, Lymphoblastic Leukemia Model +16

Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner

Anna Kreutzman, Beatriz Colom-Fernández, Ana Marcos‐Jiménez et al. · Clinical Cancer Research · 2017 · 43 citations

Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia

Carlos Cuesta‐Mateos, Sonia López-Giral, Manuel Alfonso-Pérez et al. · Experimental Hematology · 2010 · 39 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Prosurvival Pathways +9

Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma

Beatriz Somovilla-Crespo, Manuel Alfonso-Pérez, Carlos Cuesta‐Mateos et al. · Journal of Hematology & Oncology · 2013 · 39 citations · Full text